Updated November 3, 2026
A cancer diagnosis can leave you managing treatment, time away from work, and questions about your family’s future. If you used Roundup for years before being diagnosed with non-Hodgkin lymphoma, you may also be wondering whether that exposure could have played a role.
Georgia residents should know that the legal landscape has changed significantly in 2026. A U.S. Supreme Court decision limits certain Roundup lawsuits, Georgia has its own pesticide-labeling law, and a proposed nationwide settlement has separate eligibility requirements and deadlines. Understanding which rules apply to your situation is an important first step.
Key takeaways
- Settlement status: As of November 3, 2026, the September 14 final-approval hearing has taken place, but final approval remains pending.
- Supreme Court ruling: The June 2026 Durnell decision blocks the cancer-warning theory addressed in that case and creates a major barrier to similar claims.
- Latest trial: An October 29, 2026 trial ended in a defense verdict for Monsanto, the first Roundup trial after Durnell.
- Georgia verdict: The $2.065 billion Barnes verdict was followed by a confidential settlement in 2025. The verdict is not a standard payout for other patients.
- Deadlines: Lawsuit deadlines, settlement deadlines, and Georgia’s product-liability time limits require separate review.
What is the connection between Roundup and cancer?
Roundup litigation has focused largely on allegations that exposure to glyphosate-based weed killers caused non-Hodgkin lymphoma, a group of cancers affecting the lymphatic system.
Scientific and regulatory assessments have reached different conclusions. In 2015, the International Agency for Research on Cancer classified glyphosate as probably carcinogenic to humans. This is a hazard classification, rather than a prediction that a particular person’s exposure will cause cancer.
The U.S. Environmental Protection Agency’s 2017 assessment concluded that glyphosate was not likely to be carcinogenic to humans. As of November 3, 2026, EPA’s glyphosate webpage says an updated human-health risk assessment is anticipated in late 2026. That is the agency’s projected schedule, not a completed assessment.
A history of exposure and a later cancer diagnosis do not, by themselves, establish that a product caused someone’s illness. Medical evidence, exposure details, and the applicable legal standards all matter.
What changed in Roundup litigation in 2026?
The Supreme Court has ruled on cancer-warning claims
On June 25, 2026, the U.S. Supreme Court decided Monsanto Co. v. Durnell. The Court held that federal pesticide law preempted the state-law failure-to-warn claim at issue because it would require a cancer warning beyond the EPA-approved label.
In plain language, federal law blocked that claim from moving forward on its warning-label theory. This creates a significant barrier to similar claims.
The decision addressed a specific legal theory. Whether a different claim can proceed requires its own analysis. Changing the name of a claim does not necessarily avoid the ruling.
Older Georgia decisions need context
In a February 5, 2024 panel decision in Carson v. Monsanto Co., issued after an earlier full-court review, the Eleventh Circuit ruled that federal law did not preempt the Georgia failure-to-warn claim before it.
That earlier ruling no longer supports the same approach after Durnell. In an October 28, 2026 decision in Salas v. Monsanto Co., the Eleventh Circuit expressly recognized that Durnell displaced Carson and reversed a judgment on a Florida failure-to-warn claim.
For Georgia readers, this means older articles describing Carson as a clear path forward are out of date on this issue.
The first trial after Durnell ended in a defense verdict
On October 29, 2026, a St. Louis County jury returned a unanimous verdict for Monsanto in Aretino, et al. v. Monsanto Company. According to Monsanto’s trial counsel, the three plaintiffs pursued design-defect, negligence, and fraud claims after the warning-label claims were removed from the case.
The outcome shows why a claim based on a different legal theory still needs careful evaluation. It does not decide the outcome of every other patient’s case.
What is happening with the proposed Roundup settlement?
The proposed nationwide settlement provides for Monsanto to pay up to $7.25 billion, subject to its terms. The court granted preliminary approval on March 4, 2026. Preliminary approval is different from final approval.
Reuters reported that Judge Timothy Boyer held the September 14 final-approval hearing. As of November 3, 2026, the proposed settlement remains awaiting final approval.
Monsanto has begun funding the settlement, according to the administrator’s funding information in FAQ 16. Funding the settlement is different from paying individual claimants. Program and Quick-Pay Awards follow the schedules described in FAQ 20, while FAQ 21 explains Exigency Awards.
The opt-out and objection deadline was June 4, 2026. That deadline has passed.
The proposed class concerns qualifying U.S. exposure before February 17, 2026 and non-Hodgkin lymphoma claims. The administrator’s eligibility rules in FAQ 8 include additional conditions and exclusions, including rules for people with existing litigation. Exposure alone does not guarantee compensation.
What happened in the $2.1 billion Georgia Roundup case?
In March 2025, a Cobb County jury awarded $2.065 billion to John Barnes, a Dalton resident who alleged that years of Roundup use caused his non-Hodgkin lymphoma. The award included $65 million in compensatory damages and $2 billion in punitive damages.
The verdict is often rounded to $2.1 billion in headlines. On November 14, 2025, The Atlanta Journal-Constitution reported that Monsanto had settled the case on confidential terms.
The settlement amount was not disclosed, so the jury’s award should not be presented as the amount Barnes received or as a prediction of what another person could recover. The Barnes case was handled by other law firms.
Roundup litigation timeline for Georgia readers
| Date | Development | Why it matters |
|---|---|---|
| February 5, 2024 | Eleventh Circuit panel rules for Carson on federal preemption after earlier full-court review | This earlier approach was later displaced by Durnell. |
| March 2025 | Cobb County jury awards Barnes $2.065 billion | A Georgia verdict, not a standard settlement amount. |
| November 14, 2025 | AJC reports the Barnes case has settled on confidential terms | The settlement amount was not disclosed. |
| January 1, 2026 | Georgia’s pesticide warning-label provision begins applying | Adds state-law protection for qualifying labels. |
| March 4, 2026 | Proposed class settlement receives preliminary approval | Final approval is a separate step. |
| June 4, 2026 | Listed opt-out and objection deadline | This deadline has passed. |
| June 25, 2026 | Supreme Court decides Durnell | Blocks the cancer-warning claim at issue under federal law. |
| September 14, 2026 | Final-approval hearing takes place | Holding the hearing did not itself approve the settlement. |
| October 28–29, 2026 | Eleventh Circuit applies Durnell in Salas; Aretino jury finds for Monsanto | Shows the changed legal landscape in practice. |
How does Georgia’s pesticide-labeling law affect a claim?
Georgia Senate Bill 144 added O.C.G.A. § 2-7-171. Beginning January 1, 2026, the statute treats certain registered pesticides’ labels as sufficient warnings for state-law warning or labeling claims when the labels meet the specified EPA-approval or risk-assessment conditions.
The law includes a narrow exception when EPA determines that a manufacturer knowingly withheld, concealed, misrepresented, or destroyed material human-health risk information to obtain or maintain label approval.
This law concerns warning and labeling duties. Its application, together with the Supreme Court’s ruling, needs to be evaluated against the particular facts and claims.
When might a Roundup case review be helpful?
A review may be useful if you have a non-Hodgkin lymphoma diagnosis and a history of mixing, spraying, or otherwise being exposed to glyphosate-based herbicides. That history might involve landscaping, farming, grounds maintenance, or repeated use around your home.
The purpose of a review is to understand your circumstances and identify any available next steps. An attorney may ask about:
- The exact diagnosis and when you received it
- The products you used and whether they contained glyphosate
- When, where, how often, and for how many years exposure occurred
- Whether exposure happened at work, at home, or both
- Any previous lawsuit, settlement, release, or agreement affecting filing deadlines
- Any settlement notice or opt-out request
If you already have an attorney handling a Roundup claim, contact that attorney about how these developments affect your case.
What records should you gather?
Start with what you have. Useful materials may include pathology reports, oncology records, product photographs, purchase receipts, employment records, application logs, and settlement correspondence.
A simple written timeline can also help. List the approximate years you used each product, the work or household tasks involved, and when you were diagnosed. Mark uncertain dates as estimates.
You do not need a perfectly organized file before asking for help. Your medical providers remain the right people to guide your treatment and answer questions about your care.
How long do you have to take action?
Georgia generally requires personal-injury lawsuits to be brought within two years after the claim accrues under O.C.G.A. § 9-3-33. Determining when a toxic-exposure claim accrues can require more analysis than simply counting from the last day a product was used.
Wrongful death claims
Georgia wrongful death claims generally have a two-year deadline running from the date of death, subject to applicable tolling rules.
In Miles v. Ashland Chemical Co., the Georgia Supreme Court rejected extending the start date merely because a family discovered a possible chemical-exposure connection later. Families should not assume a later discovery restarts the clock.
Georgia’s ten-year product-liability limit
Georgia has a ten-year outer limit on many product claims, generally measured from the particular product’s first sale for use or consumption. Some exceptions may apply, including to certain disease-related negligence claims.
If your exposure began more than ten years ago, a lawyer should check the products, purchase dates, and type of claim before drawing a conclusion about whether you can still pursue a case.
Settlement deadlines are separate
Settlement registration and claim deadlines are separate from lawsuit filing deadlines. The proposed settlement includes deadlines tied to court approval, finality, and diagnosis dates.
Do not assume that waiting for settlement news preserves the time to file an individual lawsuit. An attorney should review the dates and documents that apply to your situation.
Frequently asked questions
Is the Roundup settlement approved?
It received preliminary approval on March 4, 2026, but final approval remains pending as of November 3, 2026, following the September 14 hearing. The hearing itself did not grant final approval.
How much could each person receive from the proposed settlement?
There is no single payout: the administrator’s award table in FAQ 20 lists Program Award tier averages from $10,000 to $165,000 and separate Quick-Pay amounts from $6,000 to $14,500 for eligible claimants. Actual awards depend on eligibility, exposure category, age, diagnosis, scoring, and other program terms; these figures are not guaranteed take-home amounts.
Did a Georgia jury award $2.1 billion in a Roundup case?
Yes. In March 2025, a Cobb County jury awarded John Barnes $2.065 billion, commonly rounded to $2.1 billion. AJC later reported that the case settled on confidential terms, so the settlement amount is not public.
Does using Roundup mean I qualify for compensation?
No. Product identity, exposure history, a qualifying diagnosis, legal deadlines, and settlement rules can all affect eligibility. Neither exposure alone nor a diagnosis alone guarantees payment.
Can I still ask for help if I missed the June 4, 2026 opt-out deadline?
Yes. You can still ask an attorney to review your status. The opt-out deadline concerned exclusion from the proposed settlement; it was not a universal deadline for every settlement benefit.
Can I pursue a claim for a different type of cancer?
The settlement discussed here focuses on non-Hodgkin lymphoma. Other diagnoses require separate medical and legal evaluation and should not be presented as automatically qualifying.
Should I wait until I finish cancer treatment to get legal guidance?
You can seek legal guidance while treatment continues. A review can help clarify deadlines and records without requiring you to have completed your medical care.
Talk with our Georgia team
You do not have to sort through settlement notices and changing legal rules on your own. If you or someone in your family has been diagnosed with non-Hodgkin lymphoma after using Roundup, Meeks Impact Law can listen to your concerns and discuss whether a further legal review makes sense.
Call 678-341-5212 to request a free, confidential case review. There is no obligation.
This article provides general information, not legal or medical advice. Eligibility, deadlines, and available claims depend on individual circumstances and applicable court orders. No outcome or compensation is guaranteed.












